Grosvenor Food & AgTech portfolio company Nuritas, a trailblazer in peptide discovery and development, has closed a $42 million Series C funding round, which also included Grosvenor, enabling it to scale its operations and expand its global customer base.

Leveraging AI and genomics, Nuritas has built the leading discovery and development platform for bioactive, cell signalling peptides – naturally occurring proteins – empowering consumers to live healthier lives by making the products they consume everyday safer, healthier and more sustainable. 

Our mission is to improve the lives of billions by creating ingredients that address pressing global health challenges,” said Dr. Nora Khaldi, Founder and CEO of Nuritas, based in Dublin, Ireland. “Through our science-first approach, we are fundamentally shifting the paradigm of ingredient discovery, enabling our customers to deliver healthier, differentiated products that meet the needs of today’s consumers. This investment, alongside the addition of experienced board members, will propel our mission to new heights.

With nearly a decade of groundbreaking research, Nuritas has built the world’s largest peptide knowledge base.

Through its AI Magnifier technology platform, Nuritas has explored billions of peptides and identified a library of more than eight million with known functionalities to create powerful, precise ingredients aimed at supercharging our natural processes.  

Its portfolio of 56 clinically-proven patented peptides covers health benefits ranging from strength, energy, and recovery, collagen production, sleep improvement and enhancing metabolism.  

They are formulated inside various FMCG products globally, allowing its customers to add transformative value and differentiation to their brands.  

Nuritas’ revolutionary peptides have attracted high-profile partnerships with leading global companies, including Givaudan, Nestlé, Mars, and Sumitomo Corporation. These collaborations highlight the broad applications of Nuritas’ bioactive peptides across functional foods, dietary supplements, medical foods, cosmetics, and food technology.